Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review

E Bauer, MS Levy, L Domachevsky, D Anaby, N Nissan - Clinical Imaging, 2022 - Elsevier
Within the past decade, background parenchymal enhancement (BPE) and background
parenchymal uptake (BPU) have emerged as novel imaging-derived biomarkers in the …

[HTML][HTML] Predictive value of background parenchymal enhancement on breast magnetic resonance imaging for pathological tumor response to neoadjuvant …

X Li, F Yan - Cancer Imaging, 2024 - Springer
Objectives This review aimed to assess the predictive value of background parenchymal
enhancement (BPE) on breast magnetic resonance imaging (MRI) as an imaging biomarker …

[HTML][HTML] Response predictivity to neoadjuvant therapies in breast cancer: a qualitative analysis of background parenchymal enhancement in DCE-MRI

D La Forgia, A Vestito, M Lasciarrea… - Journal of Personalized …, 2021 - mdpi.com
Background: For assessing the predictability of oncology neoadjuvant therapy results, the
background parenchymal enhancement (BPE) parameter in breast magnetic resonance …

[HTML][HTML] Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy

A Zdanowski, H Sartor, M Feldt, I Skarping - Frontiers in Oncology, 2023 - frontiersin.org
Objective The association between mammographic density (MD) and breast cancer (BC)
recurrence and survival remains unclear. Patients receiving neoadjuvant chemotherapy …

[HTML][HTML] Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving …

R Rella, E Bufi, P Belli, AR Scrofani, F Petta… - Diagnostic and …, 2022 - Elsevier
Purpose The purpose of this study was to retrospectively investigate whether background
parenchymal enhancement (BPE) of the contralateral breast on magnetic resonance …

Differences between ipsilateral and contralateral early parenchymal enhancement kinetics predict response of breast cancer to neoadjuvant therapy

Z Ren, FD Pineda, FM Howard, E Hill, T Szasz… - Academic …, 2022 - Elsevier
Rationale and Objectives To determine whether kinetics measured with ultrafast dynamic
contrast-enhanced magnetic resonance imaging in tumor and normal parenchyma pre-and …

多参数磁共振成像在乳腺癌新辅助化疗中的应用研究进展

路红, 季宇, 张迎, 刘佩芳 - 中国肿瘤临床, 2021 - cjco.cn
新辅助化疗(neoadjuvant chemotherapy, NAC) 作为乳腺癌综合治疗的重要组成部分,
目前依然处于不断发展的阶段. 从治疗前受益人群的选择, 治疗中方案调整 …

[HTML][HTML] Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the …

H Wang, BHM van der Velden, E Verburg… - European Journal of …, 2024 - Elsevier
Objectives Background parenchymal enhancement (BPE) on dynamic contrast-enhanced
MRI (DCE-MRI) as rated by radiologists is subject to inter-and intrareader variability. We aim …

[HTML][HTML] Background parenchymal enhancement on breast MRI: assessment and clinical implications

JS Chalfant, S Mortazavi, SA Lee-Felker - Current Radiology Reports, 2021 - Springer
Abstract Purpose of Review To present recent literature regarding the assessment and
clinical implications of background parenchymal enhancement on breast MRI. Recent …

Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer

Z Ren, FD Pineda, FM Howard, X Fan, R Nanda… - Magnetic Resonance …, 2023 - Elsevier
Purpose To assess whether measurement of the bilateral asymmetry of semiquantitative and
quantitative perfusion parameters from ultrafast dynamic contrast-enhanced MRI (DCE-MRI) …